Citigroup »

Lexeo Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $771k 49k 15.68
2023-12-31 $1.2M 92k 13.42

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Tesla Motors (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics